BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Ibrahim SM, Lewandowski RJ, Sato KT, Gates VL, Kulik L, Mulcahy MF, Ryu RK, Omary RA, Salem R. Radioembolization for the treatment of unresectable hepatocellular carcinoma: A clinical review. World J Gastroenterol 2008; 14(11): 1664-1669 [PMID: 18350597 DOI: 10.3748/wjg.14.1664]
URL: https://www.wjgnet.com/1948-5182/full/v14/i11/1664.htm
Number Citing Articles
1
Suresh Subramanian, K.V. Vimalnath, Ashutosh Dash. Preparation and preliminary in vivo evaluation of 166Ho‐labeled microspheres for possible use in radioembolic therapy of liver cancerJournal of Labelled Compounds and Radiopharmaceuticals 2018; 61(6): 509 doi: 10.1002/jlcr.3616
2
Xiao-Dong Wang, Ren-Jie Yang, Xi-Cai Cao, Jian Tan, Bin Li. Dose Delivery Estimated by Bremsstrahlung Imaging and Partition Model Correlated with Response Following Intra-arterial Radioembolization with 32P-Glass Microspheres for the Treatment of Hepatocellular CarcinomaJournal of Gastrointestinal Surgery 2010; 14(5): 858 doi: 10.1007/s11605-010-1180-4
3
Judith Meza-Junco, Aldo J. Montano-Loza, David M. Liu, Michael B. Sawyer, Vincent G. Bain, Mang Ma, Richard Owen. Locoregional radiological treatment for hepatocellular carcinoma; Which, when and how?Cancer Treatment Reviews 2012; 38(1): 54 doi: 10.1016/j.ctrv.2011.05.002
4
Charles H. Cha, M. Wasif Saif, Brett H. Yamane, Sharon M. Weber. Hepatocellular Carcinoma: Current ManagementCurrent Problems in Surgery 2010; 47(1): 10 doi: 10.1067/j.cpsurg.2009.09.003
5
Amit Singal, Jorge A. Marrero. Yamada' s Textbook of Gastroenterology2015; : 2146 doi: 10.1002/9781118512074.ch109
6
Nicholas Voutsinas, Safet Lekperic, Sharon Barazani, Joseph J. Titano, Sherif I. Heiba, Edward Kim. Treatment of Primary Liver Tumors and Liver Metastases, Part 1: Nuclear Medicine TechniquesJournal of Nuclear Medicine 2018; 59(11): 1649 doi: 10.2967/jnumed.116.186346
7
J. Arias Fernández, B. Martín Martín, N. Pinheiro da Silva, M.L. Díaz, J.I. Bilbao. Vasos extrahepáticos dependientes de la arteria hepática. Identificación y manejoRadiología 2011; 53(1): 18 doi: 10.1016/j.rx.2010.07.007
8
Yu Ma, Bo Li, Lin Li, Li-Geng Duan, Yong-Gang Wei, Xiao-Li Chen. In Vivo Distribution of 131I and 125I Dual-Labeled Gelatin Microspheres After Implantation into Rabbit LiverCancer Biotherapy and Radiopharmaceuticals 2012; 27(4): 267 doi: 10.1089/cbr.2011.1156
9
Tushar Garg, Apurva Shrigiriwar, Peiman Habibollahi, Mircea Cristescu, Robert P. Liddell, Julius Chapiro, Peter Inglis, Juan C. Camacho, Nariman Nezami. Intraarterial Therapies for the Management of Hepatocellular CarcinomaCancers 2022; 14(14): 3351 doi: 10.3390/cancers14143351
10
Shumei Ma, Benzheng Jiao, Xin Liu, Heqing Yi, Dejuan Kong, Lin Gao, Guangtong Zhao, Yu Yang, Xiaodong Liu. Approach to radiation therapy in hepatocellular carcinomaCancer Treatment Reviews 2010; 36(2): 157 doi: 10.1016/j.ctrv.2009.11.008
11
Jing-Yue Yang, Da-Yong Cao, Yan Xue, Zhao-Cai Yu, Wen-Chao Liu. Improvement of dendritic-based vaccine efficacy against hepatitis B virus–related hepatocellular carcinoma by two tumor-associated antigen gene–infected dendritic cellsHuman Immunology 2010; 71(3): 255 doi: 10.1016/j.humimm.2009.12.010
12
Tatulya Tiwari, Christopher Malone, Gretchen Foltz, Olaguoke Akinwande, Raja S. Ramaswamy. Yttrium-90 Radioembolization: Current Clinical Practice and Review of the Recent LiteratureJournal of Radiology Nursing 2019; 38(2): 86 doi: 10.1016/j.jradnu.2019.03.004
13
J. Michael Mathis, Shilpa Bhatia, Alok Khandelwal, Imre Kovesdi, Stephen J. Lokitz, Yoshi Odaka, Amol M. Takalkar, Tracee Terry, David T. Curiel, Maciej Lesniak. Genetic Incorporation of Human Metallothionein into the Adenovirus Protein IX for Non-Invasive SPECT ImagingPLoS ONE 2011; 6(2): e16792 doi: 10.1371/journal.pone.0016792
14
Erik N. K. Cressman, Matthew G. Geeslin, Mithun M. Shenoi, Leah J. Hennings, Yan Zhang, Paul A. Iaizzo, John C. Bischof. Concentration and volume effects in thermochemical ablation in vivo: Results in a porcine modelInternational Journal of Hyperthermia 2012; 28(2): 113 doi: 10.3109/02656736.2011.644621
15
Kevin Ka Wan Chu, Tan To Cheung. Update in management of hepatocellular carcinoma in Eastern populationWorld Journal of Hepatology 2015; 7(11): 1562-1571 doi: 10.4254/wjh.v7.i11.1562
16
J.J. Cuaron, J.A. Hirsch, D.C. Medich, B.S. Rosenstein, C.B. Martel, A.E. Hirsch. A Proposed Methodology to Select Radioisotopes for Use in Radionuclide TherapyAmerican Journal of Neuroradiology 2009; 30(10): 1824 doi: 10.3174/ajnr.A1773
17
Chuan-Chao Li, Jun-Lin Chi, Yu Ma, Jian-Hong Li, Chuan-Qin Xia, Lin Li, Zhuo Chen, Xiao-Li Chen. Interventional therapy for human breast cancer in nude mice with 131I gelatin microspheres (131I-GMSs) following intratumoral injectionRadiation Oncology 2014; 9(1) doi: 10.1186/1748-717X-9-144
18
Hendee's Physics of Medical Imaging, Fifth Edition2019; : 271 doi: 10.1002/9781118671016.ch8
19
Georg F. Weber. Molecular Therapies of Cancer2015; : 375 doi: 10.1007/978-3-319-13278-5_13
20
Archana Mukherjee, Suresh Subramanian, Rajwardhan Ambade, Bhaurao Avhad, Ashutosh Dash, Aruna Korde. Development of Semiautomated Module for Preparation of 131I Labeled Lipiodol for Liver Cancer TherapyCancer Biotherapy and Radiopharmaceuticals 2017; 32(1): 33 doi: 10.1089/cbr.2016.2088
21
Subhajit Ghosh, Tapas Das, Haladhar D. Sarma, Sharmila Banerjee. Preparation and preliminary bioevaluation of 68Ga-oxine in lipiodol as a potential liver imaging agentJournal of Radioanalytical and Nuclear Chemistry 2017; 311(1): 263 doi: 10.1007/s10967-016-4985-0
22
Carlo Spreafico, Carlo Morosi, Marco Maccauro, Raffaele Romito, Rodolfo Lanocita, Enrico M. Civelli, Carlo Sposito, Sherrie Bhoori, Carlo Chiesa, Laura F. Frigerio, Alice Lorenzoni, Tommaso Cascella, Alfonso Marchianò, Vincenzo Mazzaferro. Intrahepatic Flow Redistribution in Patients Treated with RadioembolizationCardioVascular and Interventional Radiology 2015; 38(2): 322 doi: 10.1007/s00270-014-0921-2
23
Zachary J. Brown, D Brock Hewitt, Timothy M Pawlik. Combination therapies plus transarterial chemoembolization in hepatocellular carcinoma: a snapshot of clinical trial progressExpert Opinion on Investigational Drugs 2022; 31(4): 379 doi: 10.1080/13543784.2022.2008355
24
Suresh Subramanian, Madhava B. Mallia, Ajit S. Shinto, Ashwathy S. Mathew. Clinical Management of Liver Cancer in India and Other Developing Nations: A Focus on Radiation Based StrategiesOncology and Therapy 2021; 9(2): 273 doi: 10.1007/s40487-021-00154-4
25
Al B. Benson, Michael I. D’Angelica, Daniel E. Abbott, Daniel A. Anaya, Robert Anders, Chandrakanth Are, Melinda Bachini, Mitesh Borad, Daniel Brown, Adam Burgoyne, Prabhleen Chahal, Daniel T. Chang, Jordan Cloyd, Anne M. Covey, Evan S. Glazer, Lipika Goyal, William G. Hawkins, Renuka Iyer, Rojymon Jacob, R. Kate Kelley, Robin Kim, Matthew Levine, Manisha Palta, James O. Park, Steven Raman, Sanjay Reddy, Vaibhav Sahai, Tracey Schefter, Gagandeep Singh, Stacey Stein, Jean-Nicolas Vauthey, Alan P. Venook, Adam Yopp, Nicole R. McMillian, Cindy Hochstetler, Susan D. Darlow. Hepatobiliary Cancers, Version 2.2021, NCCN Clinical Practice Guidelines in OncologyJournal of the National Comprehensive Cancer Network 2021; 19(5): 541 doi: 10.6004/jnccn.2021.0022
26
Steven Naymagon, Richard R. P. Warner, Kalpesh Patel, Noam Harpaz, Josef Machac, Joshua L. Weintraub, Michelle K. Kim. Gastroduodenal Ulceration Associated with Radioembolization for the Treatment of Hepatic Tumors: An Institutional Experience and Review of the LiteratureDigestive Diseases and Sciences 2010; 55(9): 2450 doi: 10.1007/s10620-010-1156-y
27
Paolo Giunchedi, Marcello Maestri, Elisabetta Gavini, Paolo Dionigi, Giovanna Rassu. Transarterial chemoembolization of hepatocellular carcinoma. Agents and drugs: an overview. Part 1Expert Opinion on Drug Delivery 2013; 10(5): 679 doi: 10.1517/17425247.2013.770733
28
A. El Mekkaoui, Z. Benbrahim, I. Charif, I. Grigoriu, J. -D. Grangé. Traitement d’un carcinome hépatocellulaire avancé associé à une thrombose porte par radioembolisation au microsphères d’Yttrium-90Journal Africain du Cancer / African Journal of Cancer 2012; 4(1): 37 doi: 10.1007/s12558-012-0203-8
29
Shi-hua Luo, Song-lin Song, Chuan-sheng Zheng, Wei-yong Li, Yong Wang, Xiang-wen Xia, Gan-sheng Feng. Embolic effects of Bletilla striata microspheres in renal artery and transplanted VX2 liver tumor model in rabbitsChinese Journal of Integrative Medicine 2019; 25(6): 431 doi: 10.1007/s11655-017-2953-3
30
Yuri S. Khotimchenko, Elena V. Khozhaenko, Maxim Y. Khotimchenko, Elena A. Kolenchenko, Valeri V. Kovalev. Carrageenans as a New Source of Drugs with Metal Binding PropertiesMarine Drugs 2010; 8(4): 1106 doi: 10.3390/md8041106
31
Jun-Lin Chi, Chuan-Chao Li, Chuan-Qin Xia, Lin Li, Yu Ma, Jian-Hong Li, Zhuo Chen, Xiao-Li Chen. Effect of131I Gelatin Microspheres on Hepatocellular Carcinoma in Nude Mice and its Distribution after Intratumoral InjectionRadiation Research 2014; 181(4): 416 doi: 10.1667/RR13539.1
32
Licia Uccelli, Micol Pasquali, Alessandra Boschi, Melchiore Giganti, Adriano Duatti. Automated preparation of Re-188 lipiodol for the treatment of hepatocellular carcinomaNuclear Medicine and Biology 2011; 38(2): 207 doi: 10.1016/j.nucmedbio.2010.08.011
33
J.-F. Dufour, I. Bargellini, N. De Maria, P. De Simone, I. Goulis, R.T. Marinho. Intermediate hepatocellular carcinoma: current treatments and future perspectivesAnnals of Oncology 2013; 24: 24 doi: 10.1093/annonc/mdt054
34
Mengchao Wu, Feng Shen, Jiamei Yang, Weiping Zhou, Yiqun Yan, Xiaohui Fu. Primary Liver Cancer2012; : 399 doi: 10.1007/978-3-642-28702-2_13
35
Liat Mlynarsky, Yoram Menachem, Oren Shibolet. Treatment of hepatocellular carcinoma: Steps forward but still a long way to goWorld Journal of Hepatology 2015; 7(3): 566-574 doi: 10.4254/wjh.v7.i3.566
36
Haiwei Zhang, Juan Zhao, Wei Yang, Zheng Li, Li Gong, Yongsheng Li. Hepatobiliary Cancers: An Interdisciplinary ApproachInterdisciplinary Cancer Research 2022; 3: 41 doi: 10.1007/16833_2022_96
37
Riccardo Lencioni, Xiao-Ping Chen, Lucy Dagher, Alan P. Venook. Treatment of Intermediate/Advanced Hepatocellular Carcinoma in the Clinic: How Can Outcomes Be Improved?The Oncologist 2010; 15(S4): 42 doi: 10.1634/theoncologist.2010-S4-42
38
Bahareh Farasati Far, Dorsa Rabie, Parisa Hemati, Parastoo Fooladpanjeh, Neda Faal Hamedanchi, Nima Broomand Lomer, Arian Karimi Rouzbahani, Mohammad Reza Naimi-Jamal. Unresectable Hepatocellular Carcinoma: A Review of New Advances with Focus on Targeted Therapy and ImmunotherapyLivers 2023; 3(1): 121 doi: 10.3390/livers3010011
39
Jorge A. Marrero. Zakim and Boyer's Hepatology2012; : 1005 doi: 10.1016/B978-1-4377-0881-3.00057-7
40
Daniel Shouval. FocusJournal of Hepatology 2013; 59(4): 643 doi: 10.1016/j.jhep.2013.07.007
41
Andrew S. Kennedy, Riad Salem. Radioembolization (Yttrium-90 Microspheres) for Primary and Metastatic Hepatic MalignanciesThe Cancer Journal 2010; 16(2): 163 doi: 10.1097/PPO.0b013e3181d7e8cf
42
Usha Pandey, Suresh Subramanian, Samina Shaikh, Naresh Gamre, Sanjukta Kumar, Ashutosh Dash. Synthesis and Preliminary Biological Evaluation of 177Lu-Labeled Polyhydroxamic Acid Microparticles Toward Therapy of Hepatocellular CarcinomaCancer Biotherapy and Radiopharmaceuticals 2019; 34(5): 306 doi: 10.1089/cbr.2018.2747
43
Riccardo Lencioni. Loco-regional treatment of hepatocellular carcinomaHepatology 2010; 52(2): 762 doi: 10.1002/hep.23725
44
A. Sabet, H. Ahmadzadehfar, J. Bruhman, A. Sabet, C. Meyer, J.-C. Wasmuth, C.-C. Pieper, H.-J. Biersack, S. Ezziddin. Survival in patients with hepatocellular carcinoma treated with 90Y-microsphere radioembolizationNuklearmedizin 2014; 53(02): 39 doi: 10.3413/Nukmed-0622-13-09
45
Harry Marquis, Juan C. Ocampo Ramos, Lukas M. Carter, Pat Zanzonico, Wesley E. Bolch, Richard Laforest, Adam L. Kesner. MIRD Pamphlet No. 29: MIRDy90—A90Y Research Microsphere Dosimetry ToolJournal of Nuclear Medicine 2024; : jnumed.123.266743 doi: 10.2967/jnumed.123.266743
46
Amr Shaaban Hanafy. Efficacy of low dose capecitabine and sorafenib in patients with advanced alfa-fetoprotein secreting hepatocellular carcinoma: a 1 year experienceSpringerPlus 2016; 5(1) doi: 10.1186/s40064-016-3376-x
47
Maarten LJ Smits, Maurice AAJ van den Bosch, Johannes FW Nijsen, Bernard A Zonnenberg. The evolution of radioembolisationThe Lancet Oncology 2012; 13(12): e519 doi: 10.1016/S1470-2045(12)70484-9
48
Saad M. Ibrahim, Laura Kulik, Talia Baker, Robert K. Ryu, Mary F. Mulcahy, Michael Abecassis, Riad Salem, Robert J. Lewandowski. Treating and Downstaging Hepatocellular Carcinoma in the Caudate Lobe with Yttrium-90 RadioembolizationCardioVascular and Interventional Radiology 2012; 35(5): 1094 doi: 10.1007/s00270-011-0292-x
49
Satoru Murata, Takahiko Mine, Fumie Sugihara, Daisuke Yasui, Hidenori Yamaguchi, Tatsuo Ueda, Shiro Onozawa, Shin-ichiro Kumita. Interventional treatment for unresectable hepatocellular carcinomaWorld Journal of Gastroenterology 2014; 20(37): 13453-13465 doi: 10.3748/wjg.v20.i37.13453
50
John J. Waddell, Patricia H. Townsend, Zachary S. Collins, Carissa Walter. Liver-Directed Therapy for Metastatic Colon Cancer: UpdateCurrent Colorectal Cancer Reports 2022; 18(1): 18 doi: 10.1007/s11888-022-00474-1
51
Stephen L. Harris, Joel E. Tepper. Radiation to the liver for hepatic metastases from colorectal cancer: Stereotactic radiotherapy and radioactive microspheresCurrent Colorectal Cancer Reports 2009; 5(3): 140 doi: 10.1007/s11888-009-0021-x
52
Veronica Goffredo, Angelo Paradiso, Girolamo Ranieri, Cosmo Damiano Gadaleta. Yttrium-90 (90Y) in the principal radionuclide therapies: An efficacy correlation between peptide receptor radionuclide therapy, radioimmunotherapy and transarterial radioembolization therapy. Ten years of experience (1999–2009)Critical Reviews in Oncology/Hematology 2011; 80(3): 393 doi: 10.1016/j.critrevonc.2011.01.012
53
M. Pracht, J. Edeline, L. Lenoir, M. Latournerie, H. Mesbah, O. Audrain, Y. Rolland, B. Clément, J. L. Raoul, E. Garin, E. Boucher. Lobar Hepatocellular Carcinoma with Ipsilateral Portal Vein Tumor Thrombosis Treated with Yttrium-90 Glass Microsphere Radioembolization: Preliminary ResultsInternational Journal of Hepatology 2013; 2013: 1 doi: 10.1155/2013/827649
54
Ali Habib, Kush Desai, Ryan Hickey, Bartley Thornburg, Robert Lewandowski, Riad Salem. Locoregional Therapy of Hepatocellular CarcinomaClinics in Liver Disease 2015; 19(2): 401 doi: 10.1016/j.cld.2015.01.008
55
José I. Bilbao, Puy Garrastachu, María J. Herráiz, Macarena Rodríguez, Mercedes Iñarrairaegui, Javier Rodríguez, Carmen Hernández, Antonio Martínez de la Cuesta, Javier Arbizu, Bruno Sangro. Safety and Efficacy Assessment of Flow Redistribution by Occlusion of Intrahepatic Vessels Prior to Radioembolization in the Treatment of Liver TumorsCardioVascular and Interventional Radiology 2010; 33(3): 523 doi: 10.1007/s00270-009-9717-1
56
Jose Enriquez, Sanaz Javadi, Ravi Murthy, Joe Ensor, Armeen Mahvash, Mohamed E Abdelsalam, David C Madoff, Michael J Wallace, Rony Avritscher. Gastroduodenal artery recanalization after transcatheter fibered coil embolization for prevention of hepaticoenteric flow: incidence and predisposing technical factors in 142 patientsActa Radiologica 2013; 54(7): 790 doi: 10.1177/0284185113481696
57
Oliver Dudeck, Karsten Bulla, Gero Wieners, Ricarda Ruehl, Gerd Ulrich, Holger Amthauer, Jens Ricke, Maciej Pech. Embolization of the Gastroduodenal Artery Before Selective Internal Radiotherapy: A Prospectively Randomized Trial Comparing Standard Pushable Coils with Fibered Interlock Detachable CoilsCardioVascular and Interventional Radiology 2011; 34(1): 74 doi: 10.1007/s00270-010-9845-7
58
Federico Aucejo, William D. Carey. Current Clinical Medicine2010; : 649 doi: 10.1016/B978-1-4160-6643-9.00098-9
59
Malcolm H. Squires, David A. Kooby. Surgical Oncology2015; : 335 doi: 10.1007/978-1-4939-1423-4_15
60
Benjamin Wiesinger, Emese Farkas, Rainer Kehlbach, Rüdiger Bantleon, Matthias Werner, Jakub Wiskirchen. Impact of Rhenium-188, Gemcitabine, and 5-Fluorouracil on Cholangiocellular Carcinoma Cells: An In Vitro StudyCardioVascular and Interventional Radiology 2009; 32(4): 737 doi: 10.1007/s00270-009-9563-1
61
Manli Jiang, F. Scott Nowakowski, Jason Wang, Sherif Heiba, Zhuangyu Zhang, Joshua Weintraub, Edward Kim, Josef Machac. Characterization of Extrahepatic Distribution of Tc-99m Macroaggregated Albumin in Hepatic Perfusion Imaging Studies Prior to Yttrium-90 Microsphere TherapyCancer Biotherapy and Radiopharmaceuticals 2011; 26(4): 511 doi: 10.1089/cbr.2010.0944
62
Brett Yamane, Sharon Weber. Liver-Directed Treatment Modalities for Primary and Secondary Hepatic TumorsSurgical Clinics of North America 2009; 89(1): 97 doi: 10.1016/j.suc.2008.10.004
63
Beatrijs A. Seinstra, Otto M. van Delden, Karel J. van Erpecum, Richard van Hillegersberg, Willem P. Th. M. Mali, Maurice A. A. J. van den Bosch. Minimally invasive image-guided therapy for inoperable hepatocellular carcinoma: What is the evidence today?Insights into Imaging 2010; 1(3): 167 doi: 10.1007/s13244-010-0027-6
64
Yuan-Yuan Zhang, Harry Hua-Xiang Xia. Novel therapeutic approaches for hepatocellulcar carcinoma: Fact and fictionWorld Journal of Gastroenterology 2008; 14(11): 1641-1642 doi: 10.3748/wjg.14.1641
65
J. Arias Fernández, B. Martín Martín, N. Pinheiro da Silva, M.L. Díaz, J.I. Bilbao. Extrahepatic vessels depending on the hepatic artery. Identification and managementRadiología (English Edition) 2011; 53(1): 18 doi: 10.1016/S2173-5107(11)70002-7
66
HUI WANG, FANG FENG, XIAO-PING WANG, ROU-SHU WANG, YING WU, MIN-GAO ZHU, HONG ZHANG, ZHI-XIANG ZHUANG. Dendritic cells pulsed with Hsp70 and HBxAg induce specific antitumor immune responses in hepatitis B virus-associated hepatocellular carcinomaMolecular Medicine Reports 2016; 13(2): 1077 doi: 10.3892/mmr.2015.4654
67
Toshihiro Furuta, Eriko Maeda, Hiroyuki Akai, Shouhei Hanaoka, Naoki Yoshioka, Masaaki Akahane, Takeyuki Watadani, Kuni Ohtomo. Hepatic Segments and Vasculature: Projecting CT Anatomy onto AngiogramsRadioGraphics 2009; 29(7): e37 doi: 10.1148/rg.e37
68
UEG Week 2016 Poster PresentationsUnited European Gastroenterology Journal 2016; 4(5_suppl): A157 doi: 10.1177/2050640616663689
69
Saad M. Ibrahim, Paul Nikolaidis, Frank H. Miller, Robert J. Lewandowski, Robert K. Ryu, Kent T. Sato, Sean Senthilnathan, Ahsun Riaz, Laura Kulik, Mary F. Mulcahy, Reed A. Omary, Riad Salem. Radiologic findings following Y90 radioembolization for primary liver malignanciesAbdominal Imaging 2009; 34(5): 566 doi: 10.1007/s00261-008-9454-y
70
Shuyi Li, Lynsa Nguyen, Hairong Xiong, Meiyao Wang, Tom C.-C. Hu, Jin-Xiong She, Steven M. Serkiz, George G. Wicks, William S. Dynan. Porous-wall hollow glass microspheres as novel potential nanocarriers for biomedical applicationsNanomedicine: Nanotechnology, Biology and Medicine 2010; 6(1): 127 doi: 10.1016/j.nano.2009.06.004
71
Da-Yong Cao, Jing-Yue Yang, Shu-Qiang Yue, Kai-Shan Tao, Zhen-Shun Song, De-Sheng Wang, Yan-Ling Yang, Ke-Feng Dou. Comparative analysis of DC fused with allogeneic hepatocellular carcinoma cell line HepG2 and autologous tumor cells as potential cancer vaccines against hepatocellular carcinomaCellular Immunology 2009; 259(1): 13 doi: 10.1016/j.cellimm.2009.05.007
72
Sudhanshu Gogia, Alex S. Befeler. Treating hepatocellular carcinoma without liver transplantationCurrent Gastroenterology Reports 2009; 11(1): 69 doi: 10.1007/s11894-009-0011-9
73
José I. Bilbao, Alba de Martino, Esther de Luis, Lourdes Díaz-Dorronsoro, Alberto Alonso-Burgos, Antonio Martínez de la Cuesta, Bruno Sangro, José A. García de Jalón. Biocompatibility, Inflammatory Response, and Recannalization Characteristics of Nonradioactive Resin Microspheres: Histological FindingsCardioVascular and Interventional Radiology 2009; 32(4): 727 doi: 10.1007/s00270-009-9592-9
74
Lourens Bester, Peter G Hobbins, Shih‐chang Wang, Riad Salem. Imaging characteristics following 90yttrium microsphere treatment for unresectable liver cancerJournal of Medical Imaging and Radiation Oncology 2011; 55(2): 111 doi: 10.1111/j.1754-9485.2011.02241.x
75
Nima Kokabi, Minzhi Xing, Richard Duszak Jr, David H Howard, Kimberly E Applegate, Juan C Camacho, Hyun S Kim. Sociodemographic impact on survival in unresectable hepatocellular carcinoma: a survival epidemiology and end results studyFuture Oncology 2016; 12(2): 183 doi: 10.2217/fon.15.242